Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals

This study has been terminated.
(Did not meet enrollment goals)
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Scott Letendre, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT01293123
First received: February 9, 2011
Last updated: June 4, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)